Microbix Biosystems Inc.
TSX:MBX.TO
0.32 (CAD) • At close October 30, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Microbix Biosystems Inc. |
Symbool | MBX.TO |
Munteenheid | CAD |
Prijs | 0.315 |
Beurswaarde | 42,737,310 |
Dividendpercentage | 0% |
52-weken bereik | 0.23 - 0.45 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Cameron L. Groome |
Website | https://microbix.com |
An error occurred while fetching data.
Over Microbix Biosystems Inc.
Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. It manufactures a range of critical biological materials for the diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment and proficiency (QAPs)
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CAD)
Cijfers zijn in miljoenen (CAD)